|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hepatitis C virus hypervariable region 1modulates receptor interactions,conceals the CD81 binding site,and protects conserved neutralizing epitopes显示文摘 | Bankwitz D Steinmann E Bitzegeio J Ciesek S Friesland M Herrmann E | | 0，，： | 1 |
| 2 | Phase Ⅱ studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer显示文摘 | Albertsson M Johansson B Friesland S | 2007 | Med Oncol2007，24，4： | 1 |
| 3 | How to improve loco-regional control in stages Ⅲa-b NSCLC Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group 显示文摘 | Nyman J Friesland S Hallqvist A | 2009 | Lung Cance2009，65，1： | 1 |
| 4 | GM-CSF at relatively high topic concentrations can significantly enhance the healng of surgically induced chronic wounds after radiotherapy显示文摘 | Femberg JO Brosjo O Friesland S | 2001 | Med Oncol2001，18，3： | 1 |
| 5 | Inactivation of hepatitis C virus infectivity by human breast milk显示文摘 | Pfaender S Heyden J Friesland M | 2013 | J Infect Dis2013，208，12： | 1 |
| 6 | Phase Ⅱ studies on docetaxel alone every third week,or weekly in combination with gemcitabine in patients with primary locally advanced,metastatic or recurrent esophageal cancer显示文摘 | Albeertsson M Johansson B Friesland S | 2007 | Med Oncol2007，24，4： | 1 |
| 7 | Phase Ⅱ studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic or recurrent esophageal cancer 显示文摘 | Albertsson M Johansson B Friesland S | 2007 | Med Oncol2007，24，4： | 1 |
| 8 | Subcellular localization and function of an epitope-tagged p7 viroporin in hepatitis c vi- rus-producing cells显示文摘 | Vieyres G Brohm C Friesland M | 2013 | J Virol2013，87，3： | 1 |
| 9 | Characterization of determinants important for hepatitis C virus p7 function in morphogenesis by using trans-complementation显示文摘 | Brohm C Steinmann E Friesland M | 2009 | Joumal of Virology2009，83，11： | 1 |
| 10 | Mapping shallow faults at the Evrona playa site using high-resolution reflection method显示文摘 | Shtivelman V Frieslander U Zilberman E | | 0，，04： | 1 |
| 11 | Mapping shallow faults at the Evrona playa site using high-resolution reflection method显示文摘 | Shtivelman V Frieslander U Zilberman E | 1998 | Geophysics1998，63，4： | 1 |
| 12 | Hepatitis C virus hypervariable region 1 modulates receptor interactions,conceals the CD81 binding site,and protects conserved neutralizing epitopes显示文摘 | Bankwitz D Steinmann E Bitzegeio J Ciesek S Friesland M Herrmann E Zeisel MB Baumert TF Keck ZY Foung SK Pécheur EI Pietschmann T | 2010 | J Virol2010，84，11： | 1 |
| 13 | Characteriza-tion of hepatitis C virus intra- and intergenotypic chimeras re-veals a role of the glycoproteins in virus envelopment 显示文摘 | Steinmann E Doerrbecker J Friesland M | 2013 | JVirol2013，87，13： | 1 |
| 14 | Durable response of cutaneous squamous cell carcinoma following high-dose peri-lesional injections of Viscum album extracts-A case report 显示文摘 | Werthmann P C~ Str~lter ~ Friesland H | 2013 | Phytomedicine2013，20，3： | 1 |
| 15 | Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma--relatian to radiotherapy response and survival 显示文摘 | Friesland S Mellin H Munck-Wikland E | 2001 | Anticancer Res2001，21，1： | 1 |
| 16 | How to improve loco-regional control in stages Ⅲ a-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group显示文摘 | Nyman J Friesland S Hallqvist A | 2009 | Lung Cancer2009，65，： | 1 |
| 17 | On the modeling and simulation of friction显示文摘 | D A Haessig Friesland | 1991 | Journal of Dynamic systems Measurement and control1991，113，： | 1 |
| 18 | Phase Ⅱ studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer 显示文摘 | Albertsson M Johansson B Friesland S | 2007 | Med Oncol2007，24，4： | 1 |
| 19 | GM-CSF at relatively high topic concentrations can significantly enhance the healing of surgically induced chronic wounds after radiotherapy显示文摘 | Fernberg JO Brosjo O Friesland S | 2001 | Med Oncol2001，18，3： | 1 |
| 20 | Phase Ⅱ studies on docetaxel alone every third week,or weekly in combination with gemcitabine in patients with primary locally advanced,metastatic,or recurrent esophageal cancer显示文摘 | Albertsson M Johansson B Friesland S | 2007 | Med Oncol2007，24，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员